Crumlin, UK, October 12, 2011 / B3C newswire / – Randox Laboratories the international clinical diagnostics company announce the launch of a new high sensitivity troponin T control. The new control allows clinical laboratories to more accurately monitor and assess the performance of their hsTnT (High Sensitivity Troponin T) assay.
Cardiac Troponins are widely used in the detection of Myocardial Infarction (MI) with even small elevations in the levels of cardiac troponin indicating damage to the heart and possible MI. In light of this both the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) recommend the use of a highly sensitive troponin assay with excellent precision (less than 10% CV) at the 99th percentile of the reference range.
Before now, suitable control materials for high sensitivity Troponin T with target values sufficiently close to the 99th percentile of the reference range (14ng/L) were unavailable. The recent launch of the Randox Acusera High Sensitivity Troponin T Control has changed things and now provides laboratories with the ability to more accurately monitor and assess the performance of their hsTnT assay.
The ultra low Troponin T levels found in the Randox control are significantly lower than those found in other manufacturers QC material. Target values for the Randox control are generally around 16.5ng/l (range 12.4 – 20.6ng/l) and are closest to the 14ng/ml cut off.
The Acusera high sensitivity troponin T control has a shelf life of up to 4 years meaning the same lot of control material can be used for longer thus reducing the problems associated with lot crossovers. A reconstituted stability of 5 days at +2 - +8oC or 4 weeks at -20oC minimises unnecessary waste and provides significant cost savings.
Randox also manufacture a liquid cardiac control with assayed values for an impressive 10 cardiac markers including BNP, CK-MB, D-dimer, Digoxin, Homocysteine, hsCRP, Myoglobin, NT-ProBNP, Troponin I and Troponin T. As the name suggests the control is liquid ready to use for added convenience and ease of us. Three levels are available spanning the complete clinical range with cut off levels for both Troponin I and T in line with international recommendations.
Headquartered in the United Kingdom, Randox Laboratories Ltd. is a market leader within the in vitro diagnostics industry, manufacturing high quality diagnostic products for laboratories worldwide. Our extensive product portfolio offers complete solutions within the fields of clinical chemistry, cardiology, forensic toxicology, veterinary, drug residues, life sciences, oncology, molecular diagnostics and internal and external quality control. Our goal is to ‘revolutionise healthcare through continuously improving diagnostic solutions.’ We continue to achieve this year after year due to our commitment and significant re-investment in Research and Development. Our innovative approach to diagnostics allows us to develop revolutionary products, specifically designed to provide more efficient, higher quality and reliable results, ensuring patients receive the right diagnosis at the right time.